To investigate whether higher expression of E33 in plasma in breast cancer patients with diabetes existed in diabetic patients without breast cancer, we used a qRT‐PCR to detect the expression levels of E33 of 35 blood samples from patients who diagnosed as type 2 diabetes without breast cancer and 35 healthy people in Medical Examination Center (MEC). Here, NDUFAF3 is linked to breast carcinoma.